» Articles » PMID: 37623615

Clinical, Epidemiological and Laboratory Features of Invasive Complex Infections in a Brazilian Pediatric Reference Hospital During the COVID-19 Pandemic

Abstract

The present study aimed to describe the clinical, epidemiological and laboratory characteristics of invasive candidiasis by complex (CPC) in a Brazilian tertiary pediatric hospital during the COVID-19 pandemic. Clinical samples were processed in the BACT/ALERT 3D system or on agar plates. Definitive identification was achieved by MALDI-TOF MS. Antifungal susceptibility was initially analyzed by the VITEK 2 system (AST-YS08 card) and confirmed by the CLSI protocol. Patient data were collected from the medical records using a structured questionnaire. CPC was recovered from 124 patients over an 18-month period, as follows: (83.87%), (13.71%) and (2.42%). Antifungal resistance was not detected. The age of the patients with invasive CPC infections ranged from <1 to 18 years, and most of them came from oncology-related sectors, as these patients were more affected by . infections were significantly more prevalent in patients from critical care units. Invasive infections caused by different pathogens occurred in 75 patients up to 30 days after the recovery of CPC isolates. Overall, 23 (18.55%) patients died within 30 days of CPC diagnosis. Catheter removal and antifungal therapy were important measures to prevent mortality. COVID-19 coinfection was only detected in one patient.

Citing Articles

Invasive candidiasis in a pediatric tertiary hospital: Epidemiology, antifungal susceptibility, and mortality rates.

Rodrigues L, Siqueira A, Vasconcelos T, Ferreira A, Spalanzani R, Krul D Med Mycol. 2024; 62(10).

PMID: 39354681 PMC: 11498051. DOI: 10.1093/mmy/myae097.

References
1.
Branco J, Miranda I, Rodrigues A . Virulence and Antifungal Resistance Mechanisms: A Comprehensive Review of Key Determinants. J Fungi (Basel). 2023; 9(1). PMC: 9862255. DOI: 10.3390/jof9010080. View

2.
Silva S, Henriques M, Martins A, Oliveira R, Williams D, Azeredo J . Biofilms of non-Candida albicans Candida species: quantification, structure and matrix composition. Med Mycol. 2009; 47(7):681-9. DOI: 10.3109/13693780802549594. View

3.
da Silva A, de Moraes-Pinto M, Pignati L, Barbosa Teixeira B, Lima A, Germano P . Candida spp bloodstream infections in a Latin American Pediatric Oncology Reference Center: Epidemiology and associated factors. Mycoses. 2020; 63(8):812-822. DOI: 10.1111/myc.13106. View

4.
Su K, Chou K, Hsiao Y, Tseng C, Su V, Lee Y . Measuring (1,3)-β-D-glucan in tracheal aspirate, bronchoalveolar lavage fluid, and serum for detection of suspected Candida pneumonia in immunocompromised and critically ill patients: a prospective observational study. BMC Infect Dis. 2017; 17(1):252. PMC: 5385026. DOI: 10.1186/s12879-017-2364-2. View

5.
Canela H, Cardoso B, Vitali L, Coelho H, Martinez R, da Silva Ferreira M . Prevalence, virulence factors and antifungal susceptibility of Candida spp. isolated from bloodstream infections in a tertiary care hospital in Brazil. Mycoses. 2017; 61(1):11-21. DOI: 10.1111/myc.12695. View